NCT02918370View on ClinicalTrials.gov

Aripiprazole for Bipolar Disorder and Alcohol Use Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Bipolar DisorderAlcoholismAlcohol Abuse
Interventions
DRUG

Aripiprazole

Aripiprazole is an atypical antipsychotic drug that is used to treat mental/mood disorders. It works to restore the balance of neurotransmitters.

DRUG

Placebo

Inactive ingredient matching the active comparators in appearance.

Trial Locations (1)

75235

UT Southwestern, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02918370 - Aripiprazole for Bipolar Disorder and Alcohol Use Disorder | Biotech Hunter | Biotech Hunter